Roivant Sciences Ltd. (ROIV) — Stock Score Summary

Roivant Sciences Ltd. (ROIV) has a MoatMap StockRank of 47/100 based on Quality (35/100), Value (35/100), and Momentum (64/100) factor scores. The current signal is HOLD. Roivant Sciences is a biotech holding company. While it has a unique model, it lacks the predictable, high-ROIC compounding characteristics of our core quality lenses.

Roivant Sciences Ltd. is a biopharmaceutical company focused on accelerating the development and commercialization of novel medicines by creating 'Vants' – specialized subsidiary companies each focused on a single therapeutic candidate. This unique 'Vant' model aims to de-risk and expedite drug development by focusing dedicated teams and capital on promising assets, fostering entrepreneurial efficiency. Roivant is an asset-centric biopharma holding company, aiming to reduce drug development costs and timelines through a decentralized structure.

Key Financial Metrics

Price$29.05
Market Cap$21.5B
P/E (Forward)-18.94
Price/Book4.91
Return on Equity-7.6%
Return on Invested Capital-21.1%
Debt/Equity2.03
Gross Margin0.0%
Operating Margin-14675.1%
Revenue Growth-66.7%
Free Cash Flow$-1.1B

Roivant Sciences Ltd. operates in the Biotechnology industry, part of the Healthcare sector (United Kingdom).

Frequently Asked Questions

What is Roivant Sciences Ltd.’s (ROIV) StockRank?
MoatMap’s StockRank for Roivant Sciences Ltd. (ROIV) is 47/100, with a Hold signal. It is a composite of Quality (35), Value (35), and Momentum (64) factor ranks across MoatMap’s 19,000+ stock universe.
Does Roivant Sciences Ltd. have an economic moat?
Roivant Sciences Ltd. (ROIV) has a Quality factor score of 35/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Roivant Sciences Ltd. a buy, hold, or sell?
MoatMap’s current signal for Roivant Sciences Ltd. (ROIV) is Hold, based on a StockRank of 47/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Roivant Sciences Ltd. in?
Roivant Sciences Ltd. (ROIV) operates in the Healthcare sector, specifically the Biotechnology industry (United Kingdom).
Browse all ranked stocksROIV deep dive reportAI ChampionsHow we score stocksSense-check another stock